Amgen Gets Favorable FDA Designation
Amgen Inc. has received a breakthrough therapy designation from the Food and Drug Administration for an investigational drug to treat advanced, metastatic non-small-cell lung cance…
Amgen Inc. has received a breakthrough therapy designation from the Food and Drug Administration for an investigational drug to treat advanced, metastatic non-small-cell lung cance…